Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: Q4Q8R1
Term | Name | Level | Count |
---|---|---|---|
GO:0000302 | response to reactive oxygen species | 4 | 2 |
GO:0001666 | response to hypoxia | 3 | 2 |
GO:0003032 | detection of oxygen | 4 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006163 | purine nucleotide metabolic process | 5 | 7 |
GO:0006164 | purine nucleotide biosynthetic process | 6 | 7 |
GO:0006171 | cAMP biosynthetic process | 8 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 7 |
GO:0006793 | phosphorus metabolic process | 3 | 7 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0006810 | transport | 3 | 2 |
GO:0006950 | response to stress | 2 | 2 |
GO:0006979 | response to oxidative stress | 3 | 2 |
GO:0007165 | signal transduction | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009117 | nucleotide metabolic process | 5 | 7 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 7 |
GO:0009152 | purine ribonucleotide biosynthetic process | 7 | 7 |
GO:0009165 | nucleotide biosynthetic process | 6 | 7 |
GO:0009187 | cyclic nucleotide metabolic process | 6 | 7 |
GO:0009190 | cyclic nucleotide biosynthetic process | 7 | 7 |
GO:0009259 | ribonucleotide metabolic process | 5 | 7 |
GO:0009260 | ribonucleotide biosynthetic process | 6 | 7 |
GO:0009593 | detection of chemical stimulus | 3 | 2 |
GO:0009628 | response to abiotic stimulus | 2 | 2 |
GO:0009987 | cellular process | 1 | 7 |
GO:0015669 | gas transport | 4 | 2 |
GO:0015671 | oxygen transport | 5 | 2 |
GO:0018130 | heterocycle biosynthetic process | 4 | 7 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 7 |
GO:0019637 | organophosphate metabolic process | 3 | 7 |
GO:0019693 | ribose phosphate metabolic process | 4 | 7 |
GO:0031279 | regulation of cyclase activity | 4 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 7 |
GO:0035556 | intracellular signal transduction | 3 | 7 |
GO:0036293 | response to decreased oxygen levels | 4 | 2 |
GO:0042221 | response to chemical | 2 | 2 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044249 | cellular biosynthetic process | 3 | 7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 |
GO:0044281 | small molecule metabolic process | 2 | 7 |
GO:0045761 | regulation of adenylate cyclase activity | 5 | 2 |
GO:0046058 | cAMP metabolic process | 7 | 7 |
GO:0046390 | ribose phosphate biosynthetic process | 5 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0050789 | regulation of biological process | 2 | 7 |
GO:0050790 | regulation of catalytic activity | 3 | 2 |
GO:0050794 | regulation of cellular process | 3 | 7 |
GO:0050896 | response to stimulus | 1 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051339 | regulation of lyase activity | 4 | 2 |
GO:0051606 | detection of stimulus | 2 | 2 |
GO:0052652 | cyclic purine nucleotide metabolic process | 6 | 7 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 7 |
GO:0065007 | biological regulation | 1 | 7 |
GO:0065009 | regulation of molecular function | 2 | 2 |
GO:0070482 | response to oxygen levels | 3 | 2 |
GO:0070483 | detection of hypoxia | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0072521 | purine-containing compound metabolic process | 4 | 7 |
GO:0072522 | purine-containing compound biosynthetic process | 5 | 7 |
GO:0090407 | organophosphate biosynthetic process | 4 | 7 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 7 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 7 |
GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
GO:1901700 | response to oxygen-containing compound | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0004016 | adenylate cyclase activity | 3 | 2 |
GO:0005344 | oxygen carrier activity | 2 | 2 |
GO:0005488 | binding | 1 | 7 |
GO:0009975 | cyclase activity | 2 | 2 |
GO:0016829 | lyase activity | 2 | 5 |
GO:0016849 | phosphorus-oxygen lyase activity | 3 | 2 |
GO:0019825 | oxygen binding | 3 | 7 |
GO:0019826 | oxygen sensor activity | 2 | 2 |
GO:0020037 | heme binding | 4 | 7 |
GO:0036094 | small molecule binding | 2 | 7 |
GO:0046906 | tetrapyrrole binding | 3 | 7 |
GO:0070025 | carbon monoxide binding | 2 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:0140104 | molecular carrier activity | 1 | 2 |
GO:0140299 | small molecule sensor activity | 1 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 428 | 432 | PF00656 | 0.423 |
CLV_C14_Caspase3-7 | 6 | 10 | PF00656 | 0.707 |
CLV_NRD_NRD_1 | 198 | 200 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 415 | 417 | PF00675 | 0.491 |
CLV_NRD_NRD_1 | 505 | 507 | PF00675 | 0.423 |
CLV_NRD_NRD_1 | 7 | 9 | PF00675 | 0.715 |
CLV_PCSK_KEX2_1 | 415 | 417 | PF00082 | 0.491 |
CLV_PCSK_KEX2_1 | 505 | 507 | PF00082 | 0.423 |
CLV_PCSK_KEX2_1 | 7 | 9 | PF00082 | 0.664 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.631 |
CLV_PCSK_PC1ET2_1 | 80 | 82 | PF00082 | 0.631 |
CLV_PCSK_SKI1_1 | 131 | 135 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 175 | 179 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.408 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.559 |
CLV_PCSK_SKI1_1 | 297 | 301 | PF00082 | 0.472 |
CLV_PCSK_SKI1_1 | 333 | 337 | PF00082 | 0.467 |
CLV_PCSK_SKI1_1 | 438 | 442 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 605 | 609 | PF00082 | 0.522 |
CLV_Separin_Metazoa | 453 | 457 | PF03568 | 0.370 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.626 |
DOC_CKS1_1 | 559 | 564 | PF01111 | 0.682 |
DOC_MAPK_gen_1 | 113 | 121 | PF00069 | 0.491 |
DOC_MAPK_gen_1 | 199 | 210 | PF00069 | 0.373 |
DOC_MAPK_gen_1 | 398 | 407 | PF00069 | 0.458 |
DOC_MAPK_gen_1 | 482 | 490 | PF00069 | 0.427 |
DOC_MAPK_gen_1 | 49 | 57 | PF00069 | 0.604 |
DOC_MAPK_HePTP_8 | 395 | 407 | PF00069 | 0.423 |
DOC_MAPK_HePTP_8 | 442 | 454 | PF00069 | 0.423 |
DOC_MAPK_MEF2A_6 | 113 | 121 | PF00069 | 0.491 |
DOC_MAPK_MEF2A_6 | 146 | 153 | PF00069 | 0.423 |
DOC_MAPK_MEF2A_6 | 203 | 210 | PF00069 | 0.435 |
DOC_MAPK_MEF2A_6 | 398 | 407 | PF00069 | 0.423 |
DOC_MAPK_MEF2A_6 | 438 | 446 | PF00069 | 0.423 |
DOC_MAPK_MEF2A_6 | 482 | 490 | PF00069 | 0.427 |
DOC_MAPK_NFAT4_5 | 203 | 211 | PF00069 | 0.547 |
DOC_PP1_RVXF_1 | 116 | 122 | PF00149 | 0.396 |
DOC_PP2B_LxvP_1 | 373 | 376 | PF13499 | 0.591 |
DOC_PP4_FxxP_1 | 324 | 327 | PF00568 | 0.370 |
DOC_USP7_MATH_1 | 343 | 347 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 376 | 380 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 406 | 410 | PF00917 | 0.491 |
DOC_USP7_UBL2_3 | 76 | 80 | PF12436 | 0.608 |
DOC_WW_Pin1_4 | 558 | 563 | PF00397 | 0.615 |
LIG_14-3-3_CanoR_1 | 278 | 284 | PF00244 | 0.438 |
LIG_14-3-3_CanoR_1 | 310 | 318 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 605 | 614 | PF00244 | 0.574 |
LIG_APCC_ABBA_1 | 179 | 184 | PF00400 | 0.291 |
LIG_APCC_ABBA_1 | 262 | 267 | PF00400 | 0.510 |
LIG_BRCT_BRCA1_1 | 378 | 382 | PF00533 | 0.536 |
LIG_BRCT_BRCA1_1 | 9 | 13 | PF00533 | 0.759 |
LIG_CaM_IQ_9 | 230 | 246 | PF13499 | 0.485 |
LIG_deltaCOP1_diTrp_1 | 195 | 202 | PF00928 | 0.374 |
LIG_eIF4E_1 | 204 | 210 | PF01652 | 0.537 |
LIG_FHA_1 | 379 | 385 | PF00498 | 0.353 |
LIG_FHA_1 | 435 | 441 | PF00498 | 0.423 |
LIG_FHA_1 | 481 | 487 | PF00498 | 0.423 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.562 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.252 |
LIG_FHA_2 | 385 | 391 | PF00498 | 0.423 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.709 |
LIG_FHA_2 | 426 | 432 | PF00498 | 0.370 |
LIG_LIR_Gen_1 | 169 | 179 | PF02991 | 0.386 |
LIG_LIR_Gen_1 | 188 | 197 | PF02991 | 0.249 |
LIG_LIR_Gen_1 | 269 | 279 | PF02991 | 0.542 |
LIG_LIR_Gen_1 | 345 | 356 | PF02991 | 0.451 |
LIG_LIR_Gen_1 | 497 | 507 | PF02991 | 0.423 |
LIG_LIR_Gen_1 | 534 | 543 | PF02991 | 0.427 |
LIG_LIR_Gen_1 | 572 | 582 | PF02991 | 0.485 |
LIG_LIR_Gen_1 | 608 | 616 | PF02991 | 0.646 |
LIG_LIR_LC3C_4 | 63 | 67 | PF02991 | 0.577 |
LIG_LIR_Nem_3 | 188 | 194 | PF02991 | 0.408 |
LIG_LIR_Nem_3 | 195 | 201 | PF02991 | 0.475 |
LIG_LIR_Nem_3 | 236 | 240 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 269 | 274 | PF02991 | 0.557 |
LIG_LIR_Nem_3 | 345 | 351 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 379 | 385 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 420 | 424 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 497 | 503 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 534 | 539 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 572 | 577 | PF02991 | 0.483 |
LIG_LIR_Nem_3 | 584 | 588 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 608 | 614 | PF02991 | 0.625 |
LIG_LIR_Nem_3 | 87 | 93 | PF02991 | 0.451 |
LIG_Pex14_1 | 350 | 354 | PF04695 | 0.411 |
LIG_Pex14_2 | 178 | 182 | PF04695 | 0.370 |
LIG_Pex14_2 | 324 | 328 | PF04695 | 0.370 |
LIG_Pex14_2 | 336 | 340 | PF04695 | 0.370 |
LIG_Pex14_2 | 348 | 352 | PF04695 | 0.355 |
LIG_Pex14_2 | 382 | 386 | PF04695 | 0.370 |
LIG_Pex14_2 | 607 | 611 | PF04695 | 0.590 |
LIG_SH2_CRK | 144 | 148 | PF00017 | 0.491 |
LIG_SH2_CRK | 500 | 504 | PF00017 | 0.423 |
LIG_SH2_PTP2 | 287 | 290 | PF00017 | 0.441 |
LIG_SH2_SRC | 287 | 290 | PF00017 | 0.441 |
LIG_SH2_STAP1 | 107 | 111 | PF00017 | 0.381 |
LIG_SH2_STAP1 | 225 | 229 | PF00017 | 0.532 |
LIG_SH2_STAP1 | 258 | 262 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 204 | 207 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 538 | 541 | PF00017 | 0.460 |
LIG_SH3_1 | 456 | 462 | PF00018 | 0.370 |
LIG_SH3_3 | 456 | 462 | PF00018 | 0.370 |
LIG_SUMO_SIM_anti_2 | 63 | 69 | PF11976 | 0.557 |
LIG_SUMO_SIM_par_1 | 63 | 69 | PF11976 | 0.510 |
LIG_TRAF2_1 | 193 | 196 | PF00917 | 0.423 |
LIG_UBA3_1 | 229 | 238 | PF00899 | 0.553 |
LIG_UBA3_1 | 290 | 298 | PF00899 | 0.288 |
LIG_WRC_WIRS_1 | 582 | 587 | PF05994 | 0.581 |
MOD_CDK_SPxxK_3 | 558 | 565 | PF00069 | 0.616 |
MOD_CK1_1 | 397 | 403 | PF00069 | 0.491 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.553 |
MOD_CK2_1 | 266 | 272 | PF00069 | 0.491 |
MOD_CK2_1 | 384 | 390 | PF00069 | 0.423 |
MOD_CK2_1 | 538 | 544 | PF00069 | 0.423 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.543 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.451 |
MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.415 |
MOD_GlcNHglycan | 359 | 362 | PF01048 | 0.419 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.636 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.498 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.674 |
MOD_GSK3_1 | 362 | 369 | PF00069 | 0.557 |
MOD_GSK3_1 | 374 | 381 | PF00069 | 0.415 |
MOD_GSK3_1 | 390 | 397 | PF00069 | 0.423 |
MOD_GSK3_1 | 425 | 432 | PF00069 | 0.423 |
MOD_GSK3_1 | 605 | 612 | PF00069 | 0.542 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.499 |
MOD_N-GLC_1 | 314 | 319 | PF02516 | 0.370 |
MOD_N-GLC_1 | 53 | 58 | PF02516 | 0.613 |
MOD_N-GLC_2 | 245 | 247 | PF02516 | 0.596 |
MOD_N-GLC_2 | 515 | 517 | PF02516 | 0.423 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.370 |
MOD_NEK2_1 | 229 | 234 | PF00069 | 0.340 |
MOD_NEK2_1 | 277 | 282 | PF00069 | 0.471 |
MOD_NEK2_1 | 328 | 333 | PF00069 | 0.491 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.582 |
MOD_NEK2_2 | 581 | 586 | PF00069 | 0.497 |
MOD_PKA_1 | 7 | 13 | PF00069 | 0.718 |
MOD_PKA_2 | 277 | 283 | PF00069 | 0.423 |
MOD_PKA_2 | 309 | 315 | PF00069 | 0.423 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.643 |
MOD_PKA_2 | 532 | 538 | PF00069 | 0.423 |
MOD_PKA_2 | 7 | 13 | PF00069 | 0.718 |
MOD_Plk_1 | 314 | 320 | PF00069 | 0.423 |
MOD_Plk_1 | 480 | 486 | PF00069 | 0.482 |
MOD_Plk_1 | 53 | 59 | PF00069 | 0.612 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.553 |
MOD_Plk_2-3 | 425 | 431 | PF00069 | 0.370 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.423 |
MOD_Plk_4 | 252 | 258 | PF00069 | 0.463 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.650 |
MOD_Plk_4 | 366 | 372 | PF00069 | 0.683 |
MOD_Plk_4 | 429 | 435 | PF00069 | 0.423 |
MOD_Plk_4 | 593 | 599 | PF00069 | 0.445 |
MOD_ProDKin_1 | 558 | 564 | PF00069 | 0.613 |
MOD_SUMO_rev_2 | 397 | 403 | PF00179 | 0.341 |
MOD_SUMO_rev_2 | 420 | 429 | PF00179 | 0.423 |
TRG_DiLeu_BaEn_1 | 590 | 595 | PF01217 | 0.541 |
TRG_DiLeu_BaEn_1 | 61 | 66 | PF01217 | 0.503 |
TRG_DiLeu_BaLyEn_6 | 413 | 418 | PF01217 | 0.491 |
TRG_ENDOCYTIC_2 | 107 | 110 | PF00928 | 0.370 |
TRG_ENDOCYTIC_2 | 221 | 224 | PF00928 | 0.440 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.441 |
TRG_ENDOCYTIC_2 | 500 | 503 | PF00928 | 0.423 |
TRG_ER_diArg_1 | 115 | 118 | PF00400 | 0.426 |
TRG_ER_diArg_1 | 414 | 416 | PF00400 | 0.491 |
TRG_ER_diArg_1 | 46 | 49 | PF00400 | 0.532 |
TRG_ER_diArg_1 | 484 | 487 | PF00400 | 0.423 |
TRG_ER_diArg_1 | 505 | 507 | PF00400 | 0.423 |
TRG_NES_CRM1_1 | 227 | 242 | PF08389 | 0.553 |
TRG_NES_CRM1_1 | 439 | 453 | PF08389 | 0.423 |
TRG_Pf-PMV_PEXEL_1 | 298 | 302 | PF00026 | 0.498 |
TRG_Pf-PMV_PEXEL_1 | 415 | 420 | PF00026 | 0.423 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P721 | Leptomonas seymouri | 69% | 89% |
A0A1X0NVA7 | Trypanosomatidae | 45% | 100% |
A0A3S7X137 | Leishmania donovani | 93% | 100% |
A4I382 | Leishmania infantum | 93% | 100% |
E9AZH0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 91% |